Clinical Lab Chat

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski discusses the critical role diagnostics play in successful organ transplantation with Tina Liedtky, president of Transplant Diagnostics for Thermo Fisher.
During the course of the lively conversation, they discuss: 
How diagnostics fit into the organ transplant process.
How diagnostics are helping to up the odds of transplant success both short and long term.
The role of post-transplantation diagnostics and how ongoing diagnostic testing helps to keep patients healthy longer.
An overview of Thermo Fisher’s transplantation diagnostics.
What advances we can expect in the next 5 to 10 years.

Keywords

Cervical Cancer, ASCCP Guidelines, HPV Testing, Self-Collection, At-Home Testing, Women's Health, Diagnostic Solutions, Preventive Care, Medical Technology, Health Access
Summary

In this episode of Clinical Lab Chat, Chris Wolski and Dr. Jeff Andrews discuss significant advancements in cervical cancer prevention, focusing on the new ASCCP guidelines, the role of technology in screening, and the importance of self-collection methods. They explore how these changes can improve access to care for women and the future of at-home testing, while also addressing the psychological barriers and stigmas associated with cervical cancer screening.
Takeaways

The ASCCP guidelines are essential for managing cervical cancer risk.
Technology has transformed how guidelines are updated and accessed.
Self-collection methods can significantly increase screening rates.
At-home testing is preferred by many women for convenience and privacy.
Addressing stigmas is crucial for increasing testing participation.
Cervical cancer is highly treatable when detected early.
The Onclarity assay provides extended genotyping for better risk assessment.
Guidelines are now more dynamic and can be updated quickly.
Improving access to care is vital for women's health.
The fight against cervical cancer is entering an exciting new phase.
Titles

Revolutionizing Cervical Cancer Prevention
The Future of Women's Health Screening
Sound Bites

"We can update guidelines very quickly now."
"The app makes it much more dynamic and useful."
"We're dealing with a couple of stigmas."
Chapters

00:00
Introduction to New Diagnostic Guidelines
02:51
Understanding ASCCP Guidelines and Their Evolution
05:30
The Role of Technology in Women's Health Testing
08:11
Onclarity HPV Assay and Its Significance
10:48
Self-Collection Methods for Cervical Cancer Screening
13:19
The Future of At-Home Testing
15:53
Impact of New Guidelines on Labs and Testing
18:32
Addressing Stigmas and Psychological Barriers
20:45
Conclusion and Future Directions
21:41
Podcast Music Outro.wav

In this episode of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, discusses the how and why of making precise clinical diagnosis of neurodegenerative diseases with Russ Lebovitz, MD, PhD, co-founder and CEO of Amprion.
 
Among the topics they discuss:
The critical importance of making accurate diagnoses of neurodegenerative diseases
Why alpha-synuclein is an accurate biomarker for a number of degenerative diseases, including Alzheimer’s
How adding neurodegenerative testing to the routine diagnostic menu would benefit patients and their caregivers
Why we’re entering a neurological healthcare “golden age”

In this episode of Clinical Lab Chat, CLP Director of Business Intelligence Chris Wolski engages in a wide-ranging discussion with Peggy Lillis Foundation CEO and founder Christian Lillis about the organization’s efforts to raise awareness of C diff. Among the topics they discuss:
 
Why C diff is difficult to diagnose
How Peggy Lillis is engaging with the public, scientific community, and legislators to improve understanding, diagnostics, and treatment of this increasingly common disease
The parallels of these awareness efforts with other public health education efforts
How laboratorians can help their organizations develop workflows to avoid under- and over-testing for C diff.

In this episode of Clinical Lab Chat, Jeff Andrews, MD, FRCSC, BD’s VP of Global Medical Affairs for Diagnostic Solutions, makes a return visit to the studio for a conversation with CLP’s director of business intelligence, Chris Wolski, about BD and MD Anderson’s collaboration on HPV sample self-collection study. 
 
Among the topics they cover:
How self-collection aids in the fight against cervical cancer
The importance of reaching underserved communities
How MD Anderson’s program is shining a light on the need for sampling options in the U.S. and across the world
The business benefits self-collection brings to labs
The impact self-collection will have in the near- and long-term